Vertex Pharmaceuticals Inc. is known worldwide for its cystic fibrosis medicines. The Boston drugmaker has won ... not a pill. Building up to a ‘blockbuster’ Myles Minter, a biotech analyst ...

Detailed price information for Vertex Inc Cl A (VERX-Q) from The Globe and Mail including charting and trades.

HAPPY BIRTHDAY — to David Edelman, Ropes & Gray’s Abby Cable; former Gov. Charlie Baker senior adviser and the NCAA’s Tim ...

Boston’s biggest lease deals in 2024 were all renewals, per Cushman & Wakefield’s research, mostly to keep the same space or add more: Vertex ... work for culture-building and mentorship.

More than 60 WBUR listeners and readers shared their stories — and photos — with us to collectively commemorate, rage and ...

ZUG, Switzerland and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE ... Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics. “Building on the success of CASGEVY’s launch, we continue ...

Today, she serves as senior director of employee relations at Vertex Pharmaceuticals ... gift for BC’s humanities building that bears their name, supporting his lifelong interest in the liberal arts.

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...

The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...

The Boston area began 2025 with a record-high office vacancy rate of 17%. Yet there are at least seven notable office ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Journavx could also appeal to prescribers seeking to minimize opioid exposure. Vertex is still tasked with building the case for Journavx across many different settings. Real-world use should help ...